RecallDepth
Class II Terminated

Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-31

This recall has been terminated (originally issued November 27, 2013).

Company
Pfizer Us Pharmaceutical Group
Recall Initiated
September 4, 2013
Posted
November 27, 2013
Recall Number
D-014-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
31 bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Distribution

US Nationwide

Lot / Code Info

Lot #: V121573, Exp 05/17

More recalls by Pfizer Us Pharmaceutical Group

View all recalls by this company →

Other recent Class II Drug recalls